Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The FDA- approved gold drug Auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.14.041228Source: DataRank Database

The FDA- approved gold drug Auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2020). On theSindex it has a DataRank of 0. It has been cited 24 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access24 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (33)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Shannon Stone ORCID,Janhavi P. Natekar ORCID,Pratima Kumari ORCID,Komal Arora ORCID,Mukesh Kumar ORCID

Live enrichment

PubMed:19910364 OpenAlex:https://openalex.org/W3016681888

National Institutes of Health

Grant: 1R21OD024896-01

A Guinea Pig Model of Zika Virus Disease

National Institutes of Health

Grant: 7R21NS099838-03

Defining the function of Schlafen4 in the pathogenesis of flavivirus encephalitis

greenLicense: https://www.biorxiv.org/about/FAQ#license

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2020/04/15/2020.04.14.041228.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2020.04.14.041228

repositoryhttps://doi.org/10.1101/2020.04.14.041228

https://doi.org/10.1016/j.virol.2020.05.002

Fields of Study

Sirtuins and Resveratrol in MedicineMosquito-borne diseases and controlEndoplasmic Reticulum Stress and Disease0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

AuranofinDrugPharmacologyDrug repositioningToxicityDrug developmentInflammationMedicineViral replicationVirologyImmunologyVirusInternal medicineSARS-CoV-2Pneumonia, ViralDrug Evaluation, PreclinicalCOVID-19Virus ReplicationAntiviral AgentsArticleCell LineBetacoronavirusCytokinesHumansGoldCoronavirus InfectionsPandemics

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being